Search Result "64Cu"
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
Journal: Current Radiopharmaceuticals
Volume: 12 Issue: 3 Year: 2019 Page: 238-246
Author(s): Ferdinando Calabria,Robert Pichler,Mario Leporace,Johannes Wolfsgruber,Pierluigi Coscarelli,Andreas Dunzinger,Orazio Schillaci,Giuseppe Lucio Cascini,Antonio Bagnato
Development of [64Cu]Cu-NODAGA-RGD-BBN as a Novel Radiotracer for Dual Integrin and GRPR-targeted Tumor PET Imaging
Journal: Current Radiopharmaceuticals
Volume: 17 Issue: 0 Year: 2024 Page: 1-9
Author(s):
Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 3-16
Author(s): T. J. Wadas, E. H. Wong, G. R. Weisman, C. J. Anderson
64Cu Labeled AmBaSar-RGD2 for micro-PET Imaging of Integrin αvβ3 Expression
Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 1 Year: 2011 Page: 68-74
Author(s): Hancheng Cai, Zibo Li, Chiun-Wei Huang, Ryan Park, Peter S. Conti
Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
Journal: Current Radiopharmaceuticals
Volume: 11 Issue: 1 Year: 2018 Page: 22-33
Author(s): Giulia Anna Follacchio,Maria Silvia De Feo,Giuseppe De Vincentis,Francesco Monteleone,Mauro Liberatore
Molecular Imaging of Cancer with Radiolabeled Peptides and PET
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 5 Year: 2012 Page: 462-475
Author(s): Amy L. Vavere,Raffaella Rossin
A Sensitive Method for the Measurement of Copper at Trace Levels Using an HPLC-Based Assay
Journal: Current Radiopharmaceuticals
Volume: 10 Issue: 1 Year: 2017 Page: 59-64
Author(s): Alan B. Packard,Jason L.J. Dearling
Recent Advances in Copper Radiopharmaceuticals
Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 2 Year: 2011 Page: 109-121
Author(s): Guiyang Hao, Ajay N. Singh, Orhan K. Oz, Xiankai Sun
Imaging Bladder Cancer
Ebook: The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9781681088655122010018
âFit for Purposeâ 64Cu Labeled Liposome Formulations Specialized for Enriched Targeting to 1) Bone Marrow Spleen; 2) lymph Nodes; or 3) Tumor
Ebook: The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9781681088655122010025